Research Article

The Burden of Noncommunicable Diseases in Ethiopia, 2000–2016: Analysis of Evidence from Global Burden of Disease Study 2016 and Global Health Estimates 2016

Table 2

Crude and ASDR/100000 population from NCD for sex and all age groups, 2000-2016.

Cause by groupCDRASDR
20002016%Change20002016%Change

All causes1475.8683.7−53.71816.71048.3−42.3
Noncommunicable diseases299.5268.5−10.3634.3554.7−12.5
Malignant neoplasms51.949.7−4.2103.693.5−9.7
Mouth and oropharynx cancers1.31.32.52.62.5−5.7
Oesophagus cancer2.21.6−26.24.83.4−29.3
Stomach cancer2.21.5−34.14.83.0−37.1
Colon and rectum cancers3.63.4−4.77.46.7−10.1
Liver cancer1.01.19.42.02.13.4
Pancreas cancer0.40.520.81.01.212.2
Trachea, bronchus, and lung cancers1.51.68.73.23.35.2
Melanoma and other skin cancers0.20.27.90.50.5−1.5
Breast cancer7.87.5−4.114.813.4−9.5
Cervix uteri cancer6.74.9−26.413.99.9−29.1
Corpus uteri cancer0.30.2−12.80.60.5−17.9
Ovary cancer1.82.535.93.64.627.5
Prostate cancer1.11.428.03.03.27.5
Testicular cancer0.10.1−39.30.20.1−42.9
Kidney cancer1.11.312.41.61.816.1
Bladder cancer0.90.9−1.42.22.0−8.9
Brain and nervous system cancers0.40.525.20.70.918.6
Gallbladder and biliary tract cancer0.70.6−14.31.31.1−18.4
Larynx cancer0.20.2−14.70.50.4−19.8
Thyroid cancer1.61.4−13.63.63.0−18.5
Mesothelioma0.10.1−29.40.20.1−35.3
Lymphomas, multiple myeloma2.93.06.15.35.42.4
Leukaemia3.53.4−2.66.05.6−5.9
Other malignant neoplasms10.410.72.219.618.9−3.7
Other neoplasms1.72.547.33.24.543.2
Diabetes mellitus12.112.75.029.929.1−2.8
Endocrine, blood, and immune disorders7.24.0−43.67.65.5−27.4
Thalassaemias1.90.7−61.60.90.4−52.2
Sickle cell disorders and trait1.60.7−54.90.90.5−45.7
Other haemoglobinopathies2.81.6−41.54.22.8−33.3
Other endocrine and immune disorders1.01.03.41.61.813.8
Mental and substance use disorders1.91.90.23.53.2−8.9
Alcohol use disorders1.41.3−11.22.82.4−15.3
Drug use disorders0.40.637.50.70.915.1
Eating disorders0.00.018.10.00.010.5
Neurological conditions10.912.413.328.430.36.8
Alzheimer disease and other dementias5.48.149.521.224.515.5
Parkinson disease0.30.559.61.21.527.5
Epilepsy4.73.3−30.85.53.7−32.0
Multiple sclerosis0.00.011.70.10.14.9
Other neurological conditions0.40.44.30.50.512.7
Cardiovascular diseases114.6106.9−6.7292.9252.9−13.7
Rheumatic heart disease3.01.4−53.35.52.7−50.9
Hypertensive heart disease7.77.6−1.321.018.8−10.7
Ischemic heart disease45.246.63.1119.5112.4−5.9
Stroke39.932.1−19.5101.174.9−26.0
Cardiomyopathy, endocarditis2.92.90.15.35.43.0
Other circulatory diseases15.916.42.740.538.7−4.5
Respiratory diseases18.515.1−18.343.034.0−20.9
Chronic obstructive pulmonary disease11.010.1−8.229.524.6−16.8
Asthma6.84.4−35.812.38.3−32.2
Other respiratory diseases0.70.6−6.91.11.1−5.6
Digestive diseases44.236.0−18.686.369.5−19.5
Peptic ulcer disease6.44.1−35.714.29.0−36.9
Cirrhosis of the liver18.016.2−9.935.330.9−12.5
Appendicitis2.11.2−42.62.61.7−34.1
Gastritis and duodenitis1.11.10.02.52.3−6.8
Paralytic ileus and intestinal obstruction8.67.3−15.915.513.2−14.7
Inflammatory bowel disease0.70.87.21.31.46.3
Gallbladder and biliary diseases1.21.2−0.32.82.6−7.3
Pancreatitis0.70.7−8.81.41.2−12.7
Other digestive diseases5.53.6−34.910.87.2−32.9
Genitourinary diseases10.19.1−9.819.718.0−9.0
Kidney diseases6.86.3−8.213.712.7−7.5
Urolithiasis0.10.127.50.10.113.3
Other urinary diseases2.92.6−11.45.44.8−10.5
Gynecological diseases0.30.2−33.70.50.3−36.6
Skin diseases2.12.412.43.74.110.2
Musculoskeletal diseases0.60.6−8.71.00.9−10.3
Rheumatoid arthritis0.20.2−21.60.50.4−22.3
Other musculoskeletal disorders0.40.4−1.10.50.50.6
Congenital anomalies21.714.1−35.110.58.5−19.0
Neural tube defects8.33.6−57.14.02.1−46.3
Cleft lip and cleft palate0.20.2−28.80.10.1−10.4
Down syndrome0.40.2−41.10.20.1−26.3
Congenital heart anomalies4.73.7−20.72.32.3−2.2
Other chromosomal anomalies0.70.811.90.30.540.0
Other congenital anomalies7.55.7−24.03.63.4−5.2
Sudden infant death syndrome1.91.1−43.30.90.6−28.7

CDR: crude death rate; ASDR: age-standardized death rate; NCD: noncommunicable disease.